The targeted protein degradation enabling technologies market, featuring a healthy pipeline of novel therapeutics, is anticipated to be worth over USD 3.3 billion by 2030, predicts Roots Analysis

Targeted protein degradation has emerged as a revolutionary pharmacological concept that presents both viable and versatile drug development opportunities and is anticipated to introduce a new paradigm in modern healthcare.

For additional details, please visit
https://www.rootsanalysis.com/reports/view_document/protein-degradation-market/289.html
 

comments (0)

64 more from jameshebrew